KZKarolina Zygoń-Komendarczyk

Karolina Zygoń-Komendarczyk

*This is an algorithmically generated author record based on publicly available information.

Karolina Zygoń-Komendarczyk has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    THE SOCIO-ECONOMIC AND CLINICAL BURDEN OF BACTERIAL BIOFILM IN CHRONIC WOUND MANAGEMENT: A SOCIO-TECHNICAL REVIEW OF ADVANCED NURSING PROTOCOLS AND COST-MITIGATION TECHNOLOGIES

    by Mikołaj Dubiel, Patryk Obajtek, Sylwia Sanakiewicz, Aleksandra Kwiatkowska, Dominik Woźniak, Karolina Zygoń-Komendarczyk

    Aim: To analyze the clinical and socio-economic impact of bacterial biofilm on chronic wound healing stagnation and to evaluate the efficacy of structured, nurse-led biofilm-disruption protocols within the TIMERS framework, focusing on contemporary cost-mitigation technologies and healthcare resource allocation. Methodology: A comprehensive narrative review of literature published between January 2010 and March 2026 was performed across PubMed, CINAHL, and the Polish Main Medical Library (GBL). Methodological quality and structural reporting were evaluated using the Scale for the Assessment of Narrative Review Articles (SANRA) guidelines to ensure systematic rigor. Results: Bacterial biofilm represents a critical biological barrier present in the majority of non-healing wounds, driving a disproportionate socio-economic burden where approximately 30% of unresolved cases consume over 70% of specialized healthcare resources. Advanced nursing interventions incorporating specialized monofilament debridement technologies, surfactant-based cleansing protocols (e.g., polihexanide), and real-time bedside fluorescence imaging significantly enhance biofilm disruption compared to conventional saline irrigation. Discussion: Implementing structured wound management strategies mitigates the economic strain on public health systems by reducing long-term nursing hours, minimizing hospitalization frequencies, and optimizing material costs. The integration of advanced wound care technologies redefines nursing competencies, requiring interdisciplinary coordination and systematic clinical frameworks. Conclusions: Transitioning from reactive to proactive, technology-driven wound care protocols managed by specialized nursing staff is essential to alleviate both clinical stagnation and systemic economic pressures.

  • Open Access

    EFFECTS OF ANABOLIC STEROID ABUSE ON THE DEVELOPMENT OF HEART FAILURE AND CARDIOVASCULAR INCIDENTS

    by Dariusz Szołtys, Katarzyna Oberska, Sandra Olewińska, Aleksandra Lisowska, Hanna Grygorcewicz, Pola Sitek, Karolina Zygoń Komendarczyk, Michalina Adamczyk, Tola Kotkiewicz, Yelyzaveta Petrenko

    Anabolic androgenic steroids (AASs) are synthetic derivatives of testosterone primarily indicated for the treatment of androgenic deficiency states. Non-clinical use of these agents has increased in recent years, particularly among athletes and individuals seeking rapid muscle hypertrophy and enhanced physical performance. Supraphysiological, off-label dosing is associated with significant systemic adverse effects. Elevated steroid levels disrupt endocrine homeostasis by suppressing the hypothalamic-pituitary-gonadal (HPG) axis. Furthermore, AAS misuse has been linked to dyslipidemia, activation of the renin-angiotensin-aldosterone system (RAAS), vascular remodeling, oxidative stress, and left ventricular hypertrophy. These mechanisms collectively add to structural remodeling of the myocardium and blood vessels, thereby increasing the risk of cardiovascular disease (CVD). Emerging evidence also indicates a higher prevalence of cardiomyopathy, arrhythmias, and premature atherosclerosis among chronic AAS users. Recent studies have associated AAS misuse with left ventricular dilation, reduced ejection fraction, and mitral regurgitation. This narrative review compiles current human-based research on the cardiovascular consequences of anabolic androgenic steroids misuse, explains the pathophysiology of CVD in this population, and highlights recommended clinical evaluations. A comprehensive literature search was executed using PubMed, Scopus, and Web of Science, focusing on original clinical cardiovascular imaging and translational studies published between 2000 and 2025.

  • Open Access

    DIAGNOSTIC PROCESS IN A LATE DIAGNOSIS OF LADD’S SYNDROME IN A 4-YEAR-OLD GIRL WITH EDWARDS SYNDROME: A CASE REPORT

    by Sylwia Sanakiewicz, Patryk Obajtek, Mikołaj Dubiel, Aleksandra Kwiatkowska, Karolina Zygoń-Komendarczyk, Dominik Woźniak

    Congenital anomalies affect 2–5% of newborns, with gastrointestinal malformations accounting for 5–6% of cases. Intestinal malrotation is a developmental disorder caused by incomplete rotation and fixation of the midgut between the 5th and 10th week of gestation. It is usually diagnosed in the neonatal period, often prenatally or within the first year of life, with more than 90% of cases identified before the age of 1. Late presentation in older children is therefore uncommon and diagnostically challenging. This case report describes an unusual late diagnosis of malrotation with Ladd’s bands in a 4-year-old girl. The aim is to emphasize that congenital gastrointestinal anomalies should remain part of the differential diagnosis of vomiting in children of any age. We report the case of a 4-year-old girl with Edwards syndrome presented with five days of coffee ground vomiting after each attempt to drink. The patient has not passed stool for one week. Ultrasound was inconclusive, and X-ray suggested right-sided diaphragmatic hernia with obstruction. A laparotomy was performed to resolve the intestinal obstruction and repair the diaphragmatic hernia. During the intraoperative bowel inspection, intestinal malrotation and associated Ladd's bands, causing duodenal obstruction, were identified. The Ladd's bands were released, and Ladd's syndrome was diagnosed. This case highlights the rare late presentation of Ladd’s syndrome in a 4-year-old child. It underlines the need to consider intestinal malrotation in the differential diagnosis of acute vomiting and bowel obstruction at any pediatric age, even when symptoms are nonspecific.

  • Open Access

    GASTROINTESTINAL ACCESS FOR ENTERAL NUTRITION IN CANCER PATIENTS: INDICATIONS, METHOD SELECTION, AND COMPLICATIONS

    by Aleksandra Kwiatkowska, Michał Becelewski, Karolina Zygoń-Komendarczyk, Dominik Woźniak, Mikołaj Dubiel, Sylwia Sanakiewicz, Patryk Obajtek

    Enteral nutrition is an integral component of comprehensive oncological treatment. This narrative review aimed to present indications for nutritional therapy in cancer patients and the principles guiding the selection of gastrointestinal access routes for enteral feeding. PubMed and Google Scholar were searched for relevant publications published between 2000 and March 2026, with particular emphasis on international guidelines and clinically relevant studies. The review summarizes the characteristics, indications, and complications of the most commonly used access methods, including nasogastric and nasojejunal tubes, percutaneous endoscopic gastrostomy (PEG), PEG with jejunal extension (PEG-J), direct percutaneous endoscopic jejunostomy (DPEJ), and surgical jejunostomy. Malnutrition remains a frequent and clinically significant problem in oncology, negatively affecting treatment tolerance, quality of life, and survival. When gastrointestinal function is preserved, enteral nutrition should be considered the preferred method of nutritional support. Appropriate selection of gastrointestinal access is essential for safe and effective nutritional therapy and reflects the growing role of medical technology and interdisciplinary collaboration in modern cancer care.

  • Open Access

    A NEURO-PATHOPHYSIOLOGICAL AND DIGITAL SYNTHESIS OF NURSING-LED FALL PREVENTION - A SYSTEMATIC LITERATURE REVIEW

    by Patryk Obajtek, Sylwia Sanakiewicz, Mikołaj Dubiel, Aleksandra Kwiatkowska, Karolina Zygoń-Komendarczyk, Dominik Woźniak

    Inpatient falls represent an exceptionally complex, multi-dimensional safety challenge that transcends simple clinical error, positioning nursing staff at the critical, high-stakes intersection of real-time clinical vigilance, neuro-pathophysiological synthesis, and macro-level systemic risk mitigation. This definitive review synthesizes high-impact evidence from the 2018–2025 period to evaluate the multifaceted, evolving role of the nurse in fall prevention, analyzing a fundamental paradigm shift from static, checklist-driven risk assessment to dynamic, systems-oriented prevention models supported by deep-learning analytics and pervasive surveillance technologies. Through a comprehensive systems-approach lens, the paper explores the quantifiable efficacy of multifactorial "safety bundles," the critical pharmacological oversight of Fall-Risk-Increasing Drugs (FRIDs), and the pervasive, often deleterious impact of organizational stressors such as nursing burnout, staffing volatility, and the "missed care" phenomenon. The methodology involved an exhaustive, multi-database systematic search of PubMed, Cochrane, and Google Scholar, identifying 17 seminal sources that demonstrate an inextricable and mathematically significant correlation between nursing workload and patient trauma incidence. Key findings suggest that while information technology provides unprecedented predictive precision, the professional clinical judgment and redundant safety layers provided by the nurse remain the only effective defense against the "Swiss Cheese" model of systemic failure. The review concludes that a sustainable, long-term reduction in fall-related injuries requires a proactive safety culture rooted in continuous professional education, structured post-fall debriefing, and an uncompromising institutional commitment to evidence-based staffing levels.

  • Open Access

    THE GUT–BRAIN AXIS IN MOOD AND ANXIETY DISORDERS: PATHOPHYSIOLOGICAL MECHANISMS, DIAGNOSTIC CHALLENGES, AND THERAPEUTIC IMPLICATIONS

    by Sandra Olewińska, Aleksandra Lisowska, Oliwia Jerzyńska, Pola Sitek, Dariusz Szołtys, Karolina Zygoń-Komendarczyk, Katarzyna Oberska, Michalina Adamczyk, Tola Kotkiewicz, Yelyzaveta Petrenko

    Over the past two decades, accumulating evidence has demonstrated bidirectional communication between the gastrointestinal tract and the central nervous system, commonly referred to as the gut–brain axis. This complex network integrates neural, hormonal, immunological, and metabolic pathways and plays a critical role in maintaining both physiological and psychological homeostasis. Increasing attention has been directed toward its involvement in mood and anxiety disorders, which constitute a major global public health challenge. This narrative review aims to synthesise current human-based research examining gut–brain axis dysfunction in mood and anxiety disorders, with particular emphasis on underlying pathophysiological mechanisms, diagnostic challenges, and emerging therapeutic strategies. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science, focusing on original clinical, neuroimaging, and translational studies published between 2000 and 2025. The available evidence indicates that alterations in gut microbiota composition, increased intestinal permeability, immune system activation, and changes in microbial metabolite production are consistently associated with depressive and anxiety-related symptoms. Moreover, the high prevalence of psychiatric comorbidity observed in functional and inflammatory gastrointestinal disorders supports the existence of shared biological pathways. Despite significant advances, the clinical translation of gut–brain research remains limited by the lack of standardised diagnostic tools and validated biomarkers. This review highlights the therapeutic potential of novel interventions, including psychobiotics, dietary modifications, and microbiota-targeted therapies, while emphasising the need for interdisciplinary collaboration and further human studies to support their integration into routine clinical practice.

  • Open Access

    SLAP II REPAIR - NEW TECHNIQUES, COMPLICATIONS AND CLINICAL OUTCOMES

    by Michalina Adamczyk, Aleksandra Lisowska, Pola Sitek, Dariusz Szołtys, Karolina Zygoń-Komendarczyk, Katarzyna Oberska, Sandra Olewińska, Tola Kotkiewicz, Hanna Grygorcewicz, Yelyzaveta Petrenko

    Superior labrum anterior to posterior (SLAP) type II lesions represent a clinically significant source of shoulder pain and dysfunction, particularly in young athletes and individuals engaged in repetitive overhead activities. Detachment of the superior labrum and biceps anchor disrupts glenohumeral biomechanics, potentially leading to instability, mechanical symptoms and impaired athletic performance. Although arthroscopic repair remains the standard surgical approach, optimal management strategies continue to evolve in response to variable return-to-sport rates and procedure-related complications observed with traditional techniques. Contemporary surgical concepts emphasize anatomic restoration of the labral-biceps complex while minimizing implant-related morbidity. Innovations such as anatomic double-pulley constructs aim to distribute fixation forces more evenly and reduce peel-back stress during overhead motion. Knotless anchor systems and low-profile suture-tape constructs have been developed to eliminate intra-articular knots, decrease chondral irritation and facilitate smoother rehabilitation. In parallel, single-portal approaches seek to reduce soft-tissue disruption without compromising biomechanical stability. For selected patients particularly those with degenerative labral tissue or advanced age, biceps-based alternatives such as tenodesis provide a viable strategy with comparable functional outcomes and potentially earlier pain relief. Early and mid-term results of these contemporary techniques demonstrate meaningful improvements in pain, shoulder function and patient satisfaction. Nevertheless, postoperative stiffness, persistent discomfort and incomplete return to high-demand activity remain clinically relevant challenges. Careful patient selection, meticulous surgical execution and individualized rehabilitation protocols are essential for optimizing outcomes. Further long-term, high-quality studies are required to refine treatment algorithms and establish durable, evidence-based recommendations.

  • Open Access

    SKIN NECROSIS FOLLOWING AESTHETIC PROCEDURES: MECHANISMS, PREVENTION, AND MANAGEMENT STRATEGIES

    by Karolina Zygoń-Komendarczyk, Aleksandra Kwiatkowska, Dominik Woźniak, Mikołaj Dubiel, Sylwia Sanakiewicz, Patryk Obajtek

    The growing global demand for minimally invasive aesthetic procedures has reshaped contemporary dermatologic and aesthetic practice. Although generally considered safe, these treatments carry a small but potentially severe risk of vascular complications. Among them, skin necrosis represents one of the most serious adverse outcomes, potentially leading to permanent scarring, tissue loss, functional impairment, and psychological distress. While dermal filler injections are most frequently implicated, ischemic injury has also been reported following autologous fat grafting, thread lifting, energy-based procedures, and deep chemical peels. This narrative review provides a clinical overview of the pathophysiology, risk factors, clinical presentation, prevention, and management of skin necrosis associated with aesthetic procedures. A literature search was conducted in PubMed, Scopus, and Web of Science for English-language publications between January 2015 and January 2025, focusing on vascular compromise and ischemic complications in aesthetic medicine. Current evidence indicates that intravascular injection and external vascular compression are the primary mechanisms leading to tissue ischemia. Early recognition of warning signs—including sudden blanching, severe pain, and livedoid discoloration—is essential, as delayed intervention increases the risk of irreversible damage. Management depends on the causative procedure, with hyaluronidase playing a central role in hyaluronic acid–related complications. Prevention relies on anatomical expertise, cautious injection techniques, and structured clinical preparedness, while standardized treatment algorithms and improved complication reporting remain essential for enhancing patient safety in modern aesthetic practice.

  • Open Access

    PLATELET-RICH PLASMA (PRP) IN MODERN DERMATOLOGY AND AESTHETIC MEDICINE: BIOLOGICAL MECHANISMS, CLINICAL APPLICATIONS, AND FUTURE DIRECTIONS

    by Karolina Zygoń-Komendarczyk, Katarzyna Oberska, Sandra Olewińska, Pola Sitek, Dariusz Szołtys, Aleksandra Lisowska, Michalina Adamczyk, Tola Kotkiewicz, Oliwia Jerzyńska, Yelyzaveta Petrenko

    Platelet-rich plasma (PRP) is an autologous blood-derived biologic increasingly used in dermatology and aesthetic medicine due to its regenerative and immunomodulatory effects. By providing a concentrated source of platelets and their mediators, PRP has the potential to enhance angiogenesis, promote collagen remodeling, and facilitate tissue repair. These properties support its application in various areas, including hair loss treatment, scar revision, chronic wound management, and minimally invasive rejuvenation procedures. This narrative review aims to summarize the current human clinical evidence regarding PRP, focusing on its biological mechanisms, preparation methods, clinical outcomes, safety profile, and future directions. A structured search was performed in PubMed, Scopus, and Web of Science for English-language studies involving human subjects published from 2010 to 2025. The search prioritized randomized controlled trials, comparative studies, and recent systematic reviews or meta-analyses. The existing evidence most strongly supports the effectiveness of PRP in treating androgenetic alopecia and as a complementary treatment for device-based acne scar therapies, such as microneedling or fractional lasers. However, significant variability in preparation techniques—such as single versus double centrifugation, platelet dosage, leukocyte content, activation methods, and treatment schedules—poses challenges for comparability and reproducibility of results. Overall, PRP is generally well tolerated, with adverse effects typically being mild and temporary. For future advancements, it will be essential to establish standardized frameworks for characterizing PRP, enhance the reporting of its composition, and conduct rigorous long-term studies that utilize technology for improved outcome assessment.